Bioequivalence Study of Two Formulations of Simvastatin Tablets in Healthy Thai Volunteers

Arzneimittel-Forschung/Drug Research

Volumn 54, Issue 1, 2004, Pages 31-34

  Lohitnavy, Manupat ^a,b   Lohitnavy, Ornrat ^a   Chaijittiprasert, Kasinee ^a   Taytiwat, Prawit ^a   Polnok, Sanglar ^a  

^a NARESUAN UNIVERSITY   (Thailand)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

CAS 79902 63 9; Simvastatin, bioequivalence study, hydroxy acid metabolite, Thai volunteers; Vascor

Indexed keywords

BEPRIDIL; HYDROXYACID; SIMVASTATIN;

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD LEVEL; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG FORMULATION; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NORMAL HUMAN; RANDOMIZATION; TABLET;

EID: 0742304367     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296933     Document Type: Article

References (6)

1. Bestehorn, H., Rensing, U., Roskamm, H. et al., The effect of simvastatin on progression of coronary artery disease: The multicenter coronary intervention study (CIS). Eur. Heart J. 18, 226 (1997)
2. Dujovne, C., The clinical therapeutic implications of the Scandinavian simvastatin survival study. Am. J. Cardiol. 79, 1387 (1997)
3. Lim, M., Foo, W., Efficacy and cost-effective of simvastatin and gemfibrozil in the treatment of hyperlipidaemia. Ann. Acad. Med. Singapore 21, 34 (1992)
4. Plosker, G., McTavish, D., Simvastatin: A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia. Drugs 50, 334 (1995)
5. Lennernas, H., Fager, G., Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors: Similarities and differences. Clin. Pharmacokinet. 32, 403 (1997)
6. Mauro, V. F., Clinical pharmacokinetics and practical applications of simvastatin. Clin. Pharmacokinet. 24, 195 (1993)